"We are an academic mood disorders research centre, providing leadership in translational research and novel opportunity treatment worldwide" #BehindTheLabel
Toronto Western Hospital
Joined November 2021
- Tweets71
- Following148
- Followers191
- Likes1.2K
Pinned Tweet
Are you a healthy individual interested in clinical research? We're currently recruiting healthy participants for a clinical trial at Toronto Western Hospital. For more details, please contact us at mdpu@uhn.ca or 416-603-5800 (ext. 5633).
Mood Disorders Psychopharmacology Unit retweeted
See our report on the Antidepressant Effects of #Psilocybin in the Absence of #Psychedelic Effects @APAPubJournals
We present the first in-human evidence to support antidepressant effects of psilocybin independent of 5HT2A and psychedelic effects
1/4
pubmed.ncbi.nlm.nih.gov/3694…
Mood Disorders Psychopharmacology Unit retweeted
Very excited about my first first-author publication! I’m grateful to be part of such an amazing lab. Many thanks to my supervisor @JD_Rosenblat for his continued support and mentorship.
Congratulations to Danica Johnson @MDPU_TWH @UofTPsych:
An update on potential pharmacotherapies for cognitive impairment in bipolar disorder
FYI Danica is studying the effect of #ketamine and #psilocybin on cognitive function so more to come!
tandfonline.com/doi/abs/10.1…
Mood Disorders Psychopharmacology Unit retweeted
Congratulations to Danica Johnson @MDPU_TWH @UofTPsych:
An update on potential pharmacotherapies for cognitive impairment in bipolar disorder
FYI Danica is studying the effect of #ketamine and #psilocybin on cognitive function so more to come!
tandfonline.com/doi/abs/10.1…
Mood Disorders Psychopharmacology Unit retweeted
Very interesting case lead by Dr Josh Rosenblat from our team that the use of a 5HTA antagonist with psilocybin did not attenuate antidepressant effect in TRD raises interesting conceptual questions on mechanisms of psilocybin effects . pubmed.ncbi.nlm.nih.gov/3694…
Mood Disorders Psychopharmacology Unit retweeted
Congrats Dr Lee @MDPU_TWH @UHN_Research @UofTPsych on another great paper
Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD
50 day free full text Link:
authors.elsevier.com/c/1gnOZ…
Do you have a clinical diagnosis of Major Depressive Disorder or Bipolar Disorder? We're currently recruiting participants for a clinical trial at Toronto Western Hospital. For more details, please contact us at mdpu@uhn.ca or 416-603-5800 (ext. 5633).
Mood Disorders Psychopharmacology Unit retweeted
Real World Effectiveness of Repeated #Ketamine Infusions for Treatment-Resistant #Depression with Comorbid #Borderline Personality Disorder
50 days #free access to full text:
authors.elsevier.com/a/1giOF…
Mood Disorders Psychopharmacology Unit retweeted
Congrats to our excellent summer student Kevork @UofTPsych on this important analysis:
Effectiveness of #Ketamine for Treatment-Resistant Depression with Comorbid Borderline Personality Disorder (BDP)
Ketamine reduced symptoms of both BPD + Depression
sciencedirect.com/science/ar…
Mood Disorders Psychopharmacology Unit retweeted
Congratulations to our very own Dr. @rogersmcintyre, the Chairman & Executive Director of the @BCDFoundation, and all the other @UHN researchers who have made the 2022 list of Highly Cited Researchers from @Clarivate! 👏
uhnresearch.ca/news/world-le…
@MDPU_TWH @UofTPsych #research
Mood Disorders Psychopharmacology Unit retweeted
Happy to see our article published in Psychiatry Research.
I am grateful to @JD_Rosenblat for their insightful supervision on this project and for all the help and support.
sciencedirect.com/science/ar…
Mood Disorders Psychopharmacology Unit retweeted
Great to see all the wonderful work happening @UofTPsych this year. Also grateful for our #psilocybin research to be featured in the Annual Report.
Advancing Treatments in Psychiatry psychiatry.utoronto.ca/news/…
Mood Disorders Psychopharmacology Unit retweeted
Huge congrats to Anastasia Levinta, a talented resident @UofTPsych who did an elective with @MDPU_TWH last year & wrote this important report:
The association between stage of treatment-resistant #depression & clinical utility of #ketamine
50d #free FT
authors.elsevier.com/a/1firK…
Mood Disorders Psychopharmacology Unit retweeted
See our national @CANMAT_org guidelines on #psychedelics out today @TheCJPsych
We hope this report will provide a helpful summary and guidance for clinicians, researchers, patients, regulators and stakeholders. 1/3
doi.org/10.1177%2F0706743722…
Mood Disorders Psychopharmacology Unit retweeted
Congratulations to Dr. Josh Rosenblat in leading the team on this very important campaign On behalf of CANMAT providing guidelines for psychedelics the first such guideline globally! pubmed.ncbi.nlm.nih.gov/3597…
Mood Disorders Psychopharmacology Unit retweeted
I am excited to have a public discussion around loneliness with my mentor @rogersmcintyre. Loneliness is just as dangerous as any other physical or mental ailment and can have far-reaching health consequences.
🔗 For twitter space. Join to get a reminder! xitter.cf/i/spaces/1lPKqmOmWanKb
Read our latest publication about Active mechanisms of ketamine-assisted psychotherapy: A systematic review🔻 #psychotherapy #mentalhealthishealth @UofT @UofTPsych sciencedirect.com/science/ar…
Congrats on an excellent paper, Isak! Isak also did a great job helping us launch our psilocybin trail last year @braxiahq
Active mechanisms of #ketamine-assisted psychotherapy: A systematic review
50 days' free full text:
authors.elsevier.com/c/1fWvf…
Mood Disorders Psychopharmacology Unit retweeted
I’m happy to be a part of this excellent paper by Isak. Read our latest review about active mechanisms of #ketamine assisted #psychotherapy.
sciencedirect.com/science/ar…